Last checked at 18 Mar 2015 07:00
Deltex Medical Group plc("Deltex Medical" or "the Company")
Director/PDMR Shareholding
18 March 2015 - Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that two Directors purchased shares in the Company.
Tim Irish, non-executive Director, notified the Company on 17 March 2015 of the purchase of 1,000,000 Ordinary Shares at a price of 6.475 pence per Ordinary Share. As a result Mr Irish's shareholding totals 2,848,484 ordinary shares (representing 1.34 per cent. of the issued share capital of Deltex Medical).
Paul Mitchell, Finance Director, notified the Company on 17 March 2015 of the purchase of 145,019 Ordinary Shares at an average price of 6.86 pence per Ordinary Share. As a result Mr Mitchell's shareholding totals 654,831 ordinary shares (representing 0.31 per cent. of the issued share capital of Deltex Medical).
For further information, please contact:-
Deltex Medical Group plc | 01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman | |
Ewan Phillips, Chief Executive | |
Paul Mitchell, Finance Director | |
Barry Curtis, Company Secretary | |
Nominated Adviser & Broker | |
Arden Partners plc | 020 7614 5900 |
Chris Hardie | |
Joint Broker Zeus Capital Limited Dominic Wilson John Goold
|
020 7533 7727
|
Financial Public Relations | |
Newgate | 020 7653 9850 |
Tim Thompson | |
Robyn McConnachie Ed Treadwell |